Latest News Archive

Please select Category, Year, and then Month to display items

Are you using the right heater in your office?

15 May 2024 | Story Valentino Ndaba | Photo Supplied

Heaters — Embrace the warmth of safety: Stay cozy with approved quartz heaters such as the Goldair GHQ-100G, keeping our campus secure and snug.

As winter approaches, the University of the Free State (UFS) is expecting increased heater usage. The Department of University Estates is proactively addressing this surge in energy demand caused by colder weather to safeguard our campuses and help mitigate the risk of loadshedding, ensuring uninterrupted operations for our staff and students.

By addressing the surge in energy demand caused by colder weather and promoting energy-efficient practices, UFS aims to play its part in alleviating the strain on the power system and contributing to national efforts to mitigate loadshedding.

With South Africa enjoying a recent break from loadshedding, Nicolaas Esterhuysen, Director of Engineering Services, stresses the importance of wise electricity usage to prevent outages and maintain safety. “During this uninterrupted power supply, it’s crucial to be mindful of our electricity usage, especially regarding heating in winter,” Esterhuysen emphasises. “By adopting energy-efficient practices, we contribute to the university’s energy-efficiency goals and create a safer environment."

In line with promoting energy efficiency, the Office for Occupational Health and Safety (OHS) is rolling out a comprehensive campaign to remove unauthorised heaters, minimising fire risks in residential and office areas.

Thato Block, Deputy Director of OHS, explains: “With the structural fire season approaching, UFS is prioritising campus safety. As colder weather looms, heaters and other warming devices will be in high demand, prompting preemptive action. OHS and the Electrical workshop will commence removing unauthorised heaters from residences and offices starting May 2024.”

Guidelines for heater usage

To ensure compliance and safety, UFS has established specific guidelines for electrical heater usage on its premises. The Standard Operating Procedure (SOP) outlines permissible and prohibited heater types, along with safety measures.

According to the SOP, only quartz heaters meeting specific criteria, such as the Goldair GHQ-100G model, are permitted on campus. These heaters are designated for offices without air conditioning, prioritising energy efficiency and safety. Furthermore, heaters are not permitted in residences due to the presence of centralised heating systems.

Prohibited models like bar, fan and oil heaters are strictly banned due to their high energy consumption and fire risks. Any unauthorised heaters found on campus will be confiscated to prevent electrical circuit overload and ensure emergency power system reliability.

In addition to regulating heater types, the UFS has implemented a stringent purchasing procedure overseen by the Department of University Estates Electrical Engineers. Approval is required before requisitioning heaters, with only quartz heaters meeting purchase criteria. This proactive approach aims to effectively manage electricity consumption, especially during peak demand periods in winter.

Safety precautions

The UFS community is reminded to exercise caution when using heaters, including maintaining a clutter-free environment around the device, and avoiding covering it. It’s also important to ensure adequate distance between the heater and flammable materials, switch off heaters when unattended, and disconnect them from power sources during prolonged periods of non-use.

Commitment to campus safety

The UFS remains committed to prioritising the safety and well-being of its community. Through proactive measures and fostering safety awareness, the university aims to create a secure environment conducive to teaching and learning throughout the year.

News Archive

Nuclear Medicine on the forefront of cancer research

2017-07-10

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma. The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept